Cambridge Independent: Vector Bioscience boosted by £2.2m Horizon Europe funding for RNA therapies

Published on March 2, 2023

Vector Bioscience, which is on the Accelerate Cambridge programme at the Entrepreneurship Centre at Cambridge Judge, is mentioned in this article about RNA-based cancer therapies. 

Read the full article [cambridgeindependent.co.uk]

The post Cambridge Independent: Vector Bioscience boosted by £2.2m Horizon Europe funding for RNA therapies appeared first on Cambridge Judge Business School.